FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

733055009: Avelumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498651015 Avelumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498652010 Avelumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Avelumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Avelumab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing avelumab Has active ingredient True Avelumab Inferred relationship Existential restriction modifier 1
Product containing avelumab in parenteral dose form (medicinal product form) Has active ingredient True Avelumab Inferred relationship Existential restriction modifier 1
Avelumab Has active ingredient True Avelumab Inferred relationship Existential restriction modifier 1
Product containing only avelumab in parenteral dose form (medicinal product form) Has active ingredient True Avelumab Inferred relationship Existential restriction modifier 1
Product containing precisely avelumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Avelumab Inferred relationship Existential restriction modifier 1
Product containing precisely avelumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Avelumab Inferred relationship Existential restriction modifier 1
Avelumab 200mg/10ml solution for infusion vials Has specific active ingredient True Avelumab Inferred relationship Existential restriction modifier
Bavencio 200mg/10ml concentrate for solution for infusion vials (Merck Serono Ltd) Has specific active ingredient True Avelumab Inferred relationship Existential restriction modifier
Avelumab 200mg/10ml solution for infusion vials 1 vial Has specific active ingredient True Avelumab Inferred relationship Existential restriction modifier
Bavencio 200mg/10ml concentrate for solution for infusion vials (Merck Serono Ltd) 1 vial Has specific active ingredient True Avelumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start